Skip to main content

Trinity College Dublin, The University of Dublin

Trinity Menu Trinity Search


Digital Health Validator Programme

Validator is a two-month digital health incubator hosted at Trinity College Dublin, the University of Dublin in collaboration with our partner EIT Health. A fulltime intensive incubator, to enable early stage Digital Health start-ups to validate their business idea and find their product/market fit in Europe.


Who’s it for?

Start-ups in digital health. We are looking for new technologies or processes that promote healthy living, support active ageing & improve health care systems. Teams must consist of minimum 2 people and maximum 4. Due to the short nature of the programme, projects requiring clinical validation will not be considered.

Why do it?

The programme is designed to help you quickly validate your technology and market potential. At the end of the 8 weeks you will show clear proof of commercial opportunity and path to profitability.

Where’s it happening?

The Validator will be hosted at Trinity, Europe’s highest-ranked university for producing entrepreneurs (Pitchbook, 2017), from 18 June to 27 July. Dublin has the perfect ecosystem for a health tech start-ups with 9 out of 10 Medtech companies based in Ireland and almost 200 funded health tech companies, it’s the perfect location to refine and validate your start-up.

Is there a European tour?

After 6 weeks intensive Validation activities at Trinity, we will take you on a two week tour of 4 health tech hubs across Europe: TU Delft, Netherlands Grenoble EM, France, Imperial College London & Newcastle University. The itinerary at each location is specifically designed for rapid market validation, in order to prove your potential for international scalability.

How much does it Cost?

It’s Free. Applicants enter the Validator for free and each team receives €5,000.
Also included: office space, expert lead workshops, mentoring from carefully selected mentors, and a tailored programme covering design thinking, leadership, business model canvas and so much more.

How do I find out more?

Please email for more information.

Meet the Teams for 2018

The 2018 Digital Health Validator Programme took place over eight weeks across June and July, check out below the teams that took part in the bootcamp

Adamant Health

NeuroTracking analysis is a solution for accurate and effective treatment of Parkinson’s disease through electricity muscle activity (EMG) and human motion analysis, using a wearable smart sensor. Our solution is based on novel, scientifically tested analysis, measurement setup and algorithms. The sensor itself is a CE Medical device. EMG is a more specific biomarker than motion. Our algorithm connects electrical activity and motion, giving better sensitivity than motion only. Connecting our AI to the electricity muscle activity makes our software unbeatable. Awarded the best idea in 2017 by OrionPharma.

Team Members: Pauli Turunen, Dr. Mika Mononen.


Avalanche has developed a 3D recognition system to replace manual documentation of deployed implants during surgical operations.

Avalanche is a medical innovation startup from Southern Germany, focused on 3D applications in trauma surgery. Our team is a mix of medical and IT professionals. There are 2 trauma surgeons, with daily hands-on experience in the operating theatre, and involved in the current ordering process of implants. Our IT professional has vast experience in managing IT projects with specialization in 3D, medical applications, artificial intelligence. A medical engineer who joined the team later on has previously developed and patented a unique bone implant.

Team Members: Alex Babanin, Dr. med. Heiko Baumgartner, Dr. med. Stefan Döbele.


Fatigue Friend prevents full blown episodes of chronic fatigue through a series of alerts based on recognising early warning stages of fatigue onset. Using this platform, a person can self-manage their fatigue, controlling their energy levels more affectively over a 24- hour period, significantly improving their quality of life.

I used to work as a clinical nurse specialist in stroke. I suffered a rare type of stroke 5 years ago which left me with ongoing cognitive impairments and chronic fatigue. Chronic fatigue is a debilitating and distressing condition. A person can go from being fit, healthy with loads of energy, to exhausted, drained and living on a battery life of 30% per day. Chronic fatigue can occur gradually due to a chronic condition, from burn out, or instantly due to an acquired brain injury or head trauma. Attacks of chronic fatigue can happen without warning – anytime, anywhere. It’s like “hitting a wall with no warning”. I have created that “warning”.

Team Members: Niamh Malone, Alison Dixon.

European Blockchain Vaccination Pass

EBV - pass is an electronic vaccination passport that uses blockchain technology enabling recording, tracking and monitoring of every vaccine administered.

There is no way for an individual to effectively track his/her vaccines record. There is no safe and secure solution to remind people it’s time for time for vaccination, keeping in mind sensitive data protection. Central registries that exist are held at a national level, so anyone moving abroad is cut-off from his/her vaccination data. We are using Hyperledger blockchain technology to create a European Blockchain Vaccination Passport. EBV-Pass provides a solution to integrate the vaccination systems of multiple countries, not just from the doctor-patient perspective, it provides vaccine traceability and a high degree of safety for sensitive patient data. EBV-pass could provide the first step to a unified healthcare record for the European Union.

Team Members: Igors Berkovics, Martin Pape, Andrii Shekhirev, Joanna Krupińska.

ELEM Biotech

Alya Red is a “virtual human” designed to optimise medical treatments for patients to improve and extend their lives.

ELEM is a start-up company conceived at the Barcelona Supercomputing Center (BSC) and host of MareNostrum supercomputer. ELEM is co-founded by BSC researchers Mariano Vázquez, Guillaume Houzeaux, José María Cela, and business consultant Chris Morton. The company has developed Alya Red, a set of simulation tools, which following a “Software-as-a-Service” model deployed in the cloud, focuses on medical devices and pharmaceutical industries. Alya Red simulates cardiovascular or respiratory systems on “virtual patients”. Combining high performance computing, computational biomechanics and data analysis, these computational avatars can be used by biomedical sector companies and clinicians to elaborate diagnoses, plan treatments, improve drug delivery and action, optimise medical devices, etc. ELEM headquarters are in Barcelona.

Team Members: Martin Vázquez, PhD; Christopher Morton, MBA; Jazmin Aguado-Sierra, PhD;
Team Member but not participating in Validator: GuillaumecHouzeaux, PhD.


Tight Alright is a ‘smart’ compression device that measures and monitors subbandage pressure for improved treatment of venous leg ulcers (VLUs).

The lifetime prevalence of VLUs in Western society is approximately 1%, rising to ~4% in the population over 65 years old. Despite compression therapy being the cornerstone to gold standard VLU treatment, inadequate application of pressure and patient non-compliance severely impair the potential for successful healing outcomes, often leading to chronic wounds. The Tight Alright connected health technology is a smart, adjustable, and reusable (cost-effective) compression bandage with inherent pressure sensing properties, which interacts with a digital interface. This product will ultimately facilitate the consistent provision of evidence-based therapy by healthcare providers or patients themselves. Furthermore, it will also serve as a tool for assessing compliance, thereby ensuring safety, efficacy, concordance, and patient empowerment. The development of Tight Alright is currently funded by an Enterprise Ireland Commercialisation Fund within the National University of Ireland Galway. The unmet clinical need was established during the EIT Health Innovation Fellowship programme, BioInnovate Ireland, where the Project Lead, Dr Andrew Cameron, was a Fellow. Dr Jaime Punter-Villagrasa has since joined as Technical Lead in the core team, which is supported by a larger team of collaborators and advisors including clinical experts, marketing/commercialisation consultants, academic partners, regulatory consultants, technical sub-contractors, and medtech entrepreneurs. Development is on track for a human study in 2019, after which a start-up company, FeelTect, will be formed in 2020.

Team Members: Dr. Andrew Cameron, Dr. Jamie Punter-Villagrasa.


Via App gives patients control of their discharge care plan from home through smart devices.

Incareview is developing the next generation of Cloud and Artificial Intelligence based applications that allows caregivers create and personalize care plans for patients on discharge from hospital. The patient, when using our VIA app, will have instant access anytime, anywhere to their care plan. This will ensure greater adherence to their doctor’s instructions, it will also lead to a significant reduction in adverse events leading to a reduction in avoidable readmissions. Our suite of applications facilitates the creation of patient engagement content and the use of this content in the development of personalized care plans that can be used by the patient in the community.

Team Members: Pat O'Donnell, Sajeesh Kesavan, Sugesh Chandran,
Team Member but not participating in Validator: Dan Byrne.


Tracworx is a patient tracking system that gives hospitals complete visibility and transparency.

Pinpoint Innovations is the creator of tracworx. Tracworx is a patient tracking system that gives hospitals complete transparency and visibility of their patients, ultimately leading to better patient flow and increased hospital efficiency. Using a simple wearable device without the need to install other infrastructure, it monitors the amount of time patients spend in each stage of their care. The product then collect more data from medical staff through tablets and desktop applications to augment and enrich the overall data set. Tracworx has been developed in collaboration with the University Hospital Limerick where it was piloted in the final 2 quarters of last year. The company’s current plans are to continue its expansion in Ireland and the UK.

Team Members: Chris Kelly, Fionn Barron, Eoin O'Brien.


Atrial Fibrillation (AF) increases the risk of stroke 5 times. Afi is an easy to use, long term monitoring system that helps GPs to prevent stroke by the early detection of AF.

Atrial Fibrillation (AF) is the most common form of arrhythmia that occurs in the developed world. It carries a high associated risk of stroke or heart failure. AF is a progressive disease with few episodes in the early stages that gradually evolve into a persistent state of AF. Although AF is generally diagnosed at a late stage, most treatments, are only effective early in the disease. Current detection systems often miss AF episodes due to their short monitoring time. They are also very obtrusive for the user. The situation is complicated further because General Practitioners (GPs), who could have a crucial role in discovering AF early, lack the proper ‘tools’ to detect AF. In response to this situation, Praxagoras is developing Afi, a long-term unobtrusive monitoring device that can be deployed by the GP, delivers an effortless and unobtrusive user experience and also provides useful insights for the treatment of the patient by cardiologists.

Team Members: Leonard Moonen, Liselotte Stolk.


WaytoB is a smartphone and smartwatch solution to enable people with intellectual disabilities to navigate by themselves, while providing peace of mind to loved ones.

Approximately 1-3% of the global population has an intellectual disability, and 60% are dependent on others for transportation and assistance to access social activities. WaytoB allows user navigation to safely reach their destination by following icon-based instructions displayed on their smartwatch. With 3 years of research, and 12 prototypes developed, out latest model is currently being user tested by 20 people.

Team Members: Talita Holzer, Robbie Fryers.